Avalyn Pharma (AVLN) news
Recent news
Avalyn appoints Robert J. Meyer, MD, to its board of directors
Avalyn has announced the appointment of Robert J. Meyer, MD, to its board of directors, bringing extensive experience in pharmaceutical development and regulatory affairs. Dr. Meyer has over 30 years of leadership experience in academic, industry, and government roles, including a senior position…
AInvest Wire · Sep 16, 2026Avalyn Pharma - topline data from MIST trial expected in second half of 2027
Avalyn Pharma is currently conducting the MIST Study, a Phase 2b clinical trial evaluating the safety and efficacy of AP01, an inhaled formulation of pirfenidone, for the treatment of Progressive Pulmonary Fibrosis (PPF). The trial is designed as a randomized, double-blind, placebo-controlled study…
AInvest Wire · Jun 17, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.